These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 10833899)
1. Biochemical and morphological study on liver Golgi complex in streptozotocin-diabetic and control rats treated with bis(kojato)oxovanadium(IV) [VO(ka)2]x2H2O. Part II. Prolonged treatmentwith vanadium compound. Dabroś W; Gryboś R; Miarka A; Kordowiak AM Pol J Pathol; 2000; 51(1):17-24. PubMed ID: 10833899 [TBL] [Abstract][Full Text] [Related]
2. Biochemical and morphological study on liver Golgi complex in streptozotocin-diabetic and control rats treated with bis(kojato)oxovanadium(IV) [VO(ka)2]x2H2O. Part I. One week treatment with vanadium compound. Kordowiak AM; Nikiforuk A; Dabroś W Pol J Pathol; 2000; 51(1):9-16. PubMed ID: 10833898 [TBL] [Abstract][Full Text] [Related]
3. The influence of a new vanadium compound, bis(2,2'-bipyridine)oxovanadium(IV) sulphate on liver golgi complexes from control and streptozotocin-diabetic rats. Kordowiak AM; Dabroś W; Kajda B Horm Metab Res; 2002 Oct; 34(10):556-60. PubMed ID: 12439783 [TBL] [Abstract][Full Text] [Related]
4. The influence of BMOV [bis(maltolato)oxovanadium(IV)] on biochemical and morphological alterations characteristic for streptozotocin-diabetic rat liver Golgi complexes. Dabroś W; Dziga D; Kordowiak AM Pol J Pathol; 2002; 53(4):205-13. PubMed ID: 12597338 [TBL] [Abstract][Full Text] [Related]
5. Control and STZ-diabetic rat liver Golgi complexes under the influence of bis(2,2'-bipyridine)oxovanadium(IV) sulphate. The morphological investigation. Dabroś W; Kajda B; Kordowiak AM Pol J Pathol; 2002; 53(3):123-8. PubMed ID: 12476613 [TBL] [Abstract][Full Text] [Related]
6. Morphology and biochemical activity of rat liver golgi complexes after pretreatment with bis(kojato)oxovanadium(IV) or kojic acid alone. Dabroś W; Nikiforuk A; Kordowiak AM Pol J Pathol; 2004; 55(3):15-21. PubMed ID: 15619976 [TBL] [Abstract][Full Text] [Related]
7. Sodium metavanadate affected control and streptozotocin-diabetic rat liver golgi complexes. Dabroś W; Goc A; Turyna B; Kordowiak AM Pol J Pathol; 2006; 57(2):91-7. PubMed ID: 17019971 [TBL] [Abstract][Full Text] [Related]
8. Influence of bis(maltolato)oxovanadium(IV) on activity of galactosyltransferase (GalT) and morphology of rat liver Golgi apparatus in control and streptozotocin diabetes. Dabroś W; Kordowiak AM; Dziga D; Gryboś R Pol J Pathol; 1998; 49(2):67-76. PubMed ID: 9798409 [TBL] [Abstract][Full Text] [Related]
9. Streptozotocin-induced alterations in rat liver Golgi complexes are ameliorated by BMOV [Bis(maltolato)oxovanadium(IV)] activity. Kordowiak AM; Dziga D; Dabroś W Horm Metab Res; 2004 Mar; 36(3):148-54. PubMed ID: 15057667 [TBL] [Abstract][Full Text] [Related]
10. Influence of vanadyl sulphate [VOSO4] on biochemical activity and morphology of control and streptozotocin-diabetic rat liver Golgi complexes. Dabroś W; Goc A; Turyna B; Kordowiak AM Pol J Pathol; 2004; 55(1):25-32. PubMed ID: 15195703 [TBL] [Abstract][Full Text] [Related]
11. Effects of bis(alpha-furancarboxylato)oxovanadium(IV) on glucose metabolism in fat-fed/streptozotocin-diabetic rats. Niu Y; Liu W; Tian C; Xie M; Gao L; Chen Z; Chen X; Li L Eur J Pharmacol; 2007 Oct; 572(2-3):213-9. PubMed ID: 17651728 [TBL] [Abstract][Full Text] [Related]
12. Sodium orthovanadate exerts influence on liver Golgi complexes from control and streptozotocin-diabetic rats. Kordowiak AM; Goc A; Drozdowska E; Turyna B; Dabros W J Inorg Biochem; 2005 May; 99(5):1083-9. PubMed ID: 15833331 [TBL] [Abstract][Full Text] [Related]
13. Influence of LEPK on biochemical activity and morphology in situ of liver Golgi apparatus from control and streptozotocin-diabetic rats. Kordowiak AM; Polański M; Dabroś W Pol J Pathol; 1997; 48(2):87-93. PubMed ID: 9278104 [TBL] [Abstract][Full Text] [Related]
14. Insulin-like effects on liver Golgi membrane preparations of bis(oxalato)oxovanadate(IV) complex ion, a new vanadate compound. Kordowiak AM; Trzos R; Grybos R Horm Metab Res; 1997 Mar; 29(3):101-5. PubMed ID: 9137978 [TBL] [Abstract][Full Text] [Related]
15. Biochemical and morphological alterations in rat liver Golgi complexes after treatment with bis(maltolato)oxovanadium(IV) [BMOV] or maltol alone. Dabroś W; Dziga D; Gryboś R; Kordowiak AM Pathol Res Pract; 2000; 196(8):561-8. PubMed ID: 10982019 [TBL] [Abstract][Full Text] [Related]
16. Acute and chronic response to vanadium following two methods of streptozotocin-diabetes induction. Yao J; Battell ML; McNeill JH Can J Physiol Pharmacol; 1997 Feb; 75(2):83-90. PubMed ID: 9114928 [TBL] [Abstract][Full Text] [Related]
17. Aqueous chemistry of the vanadium(III) (V(III)) and the V(III)-dipicolinate systems and a comparison of the effect of three oxidation states of vanadium compounds on diabetic hyperglycemia in rats. Buglyó P; Crans DC; Nagy EM; Lindo RL; Yang L; Smee JJ; Jin W; Chi LH; Godzala Iii ME; Willsky GR Inorg Chem; 2005 Jul; 44(15):5416-27. PubMed ID: 16022540 [TBL] [Abstract][Full Text] [Related]
18. Effects of bis(alpha-furancarboxylato)oxovanadium(IV) on non-diabetic and streptozotocin-diabetic rats. Gao LH; Liu WP; Wang BL; Li L; Xie MJ; Li YR; Chen ZH; Chen XZ Clin Chim Acta; 2006 Jun; 368(1-2):173-8. PubMed ID: 16487949 [TBL] [Abstract][Full Text] [Related]
19. Anti-diabetic effects of vanadium(III, IV, V)-chlorodipicolinate complexes in streptozotocin-induced diabetic rats. Li M; Ding W; Smee JJ; Baruah B; Willsky GR; Crans DC Biometals; 2009 Dec; 22(6):895-905. PubMed ID: 19404749 [TBL] [Abstract][Full Text] [Related]
20. Anti-diabetic effects of cesium aqua (N,N'-ethylene(salicylideneiminato)-5-sulfonato) oxovanadium (IV) dihydrate in streptozotocin-induced diabetic rats. Li M; Wei D; Ding W; Baruah B; Crans DC Biol Trace Elem Res; 2008 Mar; 121(3):226-32. PubMed ID: 17968514 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]